Immunotherapy and its toxicity made simple.

We are medical oncologists and best buddies with a shared passion for cancer immunotherapies. We are fascinated by the amazing outcomes achieved and the day-to-day challenges these drugs present. We love nothing more than a chat between friends and colleagues about all things immunotherapy, with Ricky despairing of Anna’s love for all things pharmacology, and Anna marveling at Ricky’s long-held desire to give Immunotherapy in the pub!

Join Prof Ricky Frazer and Prof Anna Olsson-Brown as they explore the challenges, progress, and real-world dilemmas in cancer immunotherapy with expert insights and special guests.

Listen to our podcast on :

Our Latest Podcast.

Episode 61: Patient Podcast Number 6 – medical jargon demystified

Episode 60: Patient Podcast Number 5 – impact on me and my family

Episode 59: Patient Podcast Number 4 – Treatment journey, side effects and after-care

Episode 58: Patient Podcast Number 3 – Family, friends and career

Episode 57: Patient Podcast Number 2 – During immunotherapy / side effects explained

Episode 56: Patient Podcast Number 1 – Fundamentals of Immunotherapy

Enjoy Our Podcast

Explore Immunotherapy. Tune In. Learn. Stay Updated.

Join expert-led conversations on immunotherapy, cancer care, and real clinical challenges. Stay informed with practical insights designed for clinicians, students, and patients. New episodes are released every Friday.

Downloads

0 +

Countries

Cities

Making Immunotherapy and Cancer Care Easier to Understand

The Immunobuddies Podcast explores the challenges, progress, and real-world experiences of patients receiving immunotherapy. Hosted by Professor Ricky Frazer and Professor Anna Olsson-Brown, the podcast brings together expert insights, clinical discussions, and practical knowledge.

From complex toxicities to the latest developments in cancer treatment, each episode is designed to make serious science more accessible, engaging, and easier to apply in clinical practice. New episodes are released every Friday, keeping you updated on the latest advancements in immunotherapy and cancer care.